Arixon® (Ceftriaxone) is a 3rd generation parenteral Cephalosporin. It is highly stable to most beta-lactamase, both Penicillinases and Cephalosporinases of Gram-positive and Gram-negative bacteria. The action of Arixon is bactericidal which inhibits the cell wall synthesis. Arixon is indicated for pneumonia, typhoid, UTI, otitis media, gonorrhea, chancroid, syphilis, SSTI, UTI, meningitis, prophylaxis of post-operative infections, septicemia, infections in cancer patients and miscellaneous bacterial infections.
• Globally accepted treatment in a wide spectrum of indications
• Assures the quality Ceftriaxone for the patients
• Globally accepted treatment in a wide spectrum of indications
• Assures the quality Ceftriaxone for the patients
0 comments:
Post a Comment